Works matching IS 02724391 AND DT 2010 AND VI 71 AND IP 8
Results: 9
Meeting the information needs of a national drug payer: aspirations of the guidelines from Australia.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 463, doi. 10.1002/ddr.20425
- By:
- Publication type:
- Article
Informing resource allocation decision making: economic evaluations of pharmacogenetic tests.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 445, doi. 10.1002/ddr.20429
- By:
- Publication type:
- Article
How does NICE value innovation?
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 449, doi. 10.1002/ddr.20423
- By:
- Publication type:
- Article
Implementation of innovative pharmacogenetic tests into practice in Taiwan: an institutional perspective.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 502, doi. 10.1002/ddr.20427
- By:
- Publication type:
- Article
Pharmaceutical market access and the challenges of health technology assessment in the United Kingdom.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 478, doi. 10.1002/ddr.20422
- By:
- Publication type:
- Article
Impact of DNA patents on pharmacogenomics research and development: economic and policy issues.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 485, doi. 10.1002/ddr.20419
- By:
- Publication type:
- Article
Using an iterative approach to economic evaluation in the drug development process.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 470, doi. 10.1002/ddr.20421
- By:
- Publication type:
- Article
The increasing role of health economic evaluations in drug development.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 457, doi. 10.1002/ddr.20420
- By:
- Publication type:
- Article
Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.
- Published in:
- Drug Development Research, 2010, v. 71, n. 8, p. 492, doi. 10.1002/ddr.20424
- By:
- Publication type:
- Article